Share:
Second Sight Medical Products Inc. (NASDAQ: EYES) shares gapped up Wednesday morning following the two-year results from the company’s Orion Study in visual prosthetics.
Four out of five patients are able to better identify the direction of motion of a bar moving across a computer screen with the Orion System on, with only one adverse event occurring.
Second Sight was up 33.2% at $6.66 at last check.
Second Sight Daily Chart Analysis
Second Sight shares look to be trading in what technical traders may call a falling wedge pattern.
The stock is trading below the 50-day moving average (green), but above the 200-day moving average (blue), indicating the stock is most likely facing a period of consolidation.
Amazon, Inc. (NASDAQ: AMZN) in the US.
Each test kit, according to the company, provides a PCR quality test result at home in 30 minutes or less. After testing, users can also receive a free, text-based digital LUCI PASS verified test result on their phone for work or travel. The product costs $55 and includes free standard shipping.
Lucira focuses on developing and commercializing infectious disease test kits.
Lucira shares were rallying 17.09% to $5.96.
Ra Medical Jumps: Medical device company Ra Medical reported a narrower-than-expected loss of $2.48 million and better-than-expected revenues of $1.1 million for the first quarter.
The company, which commercializes excimer lasers and catheters for the treatment of vascular and dermatological diseases, noted an improvement in dermatology revenues, as COVID-19 restrictions are lifted.
April 7, 2015
Issued to WiperFill Holdings LLC. Matthew Carroll invented a system of collecting rainwater to replenish a windshield wiper reservoir and windshield washer conditioner.
June 19, 2018
Issued to Raytheon Company. Joseph Marron invented a coherent ladar using intra-pixel quadrature detection, with applications in such varied fields as autonomous vehicles, medical imaging devices, military defense systems, and space and undersea exploration.
May 11, 2021
Issued to 4C Medical Technologies, Inc. Co-inventors Saravana B. Kumar and Jason S. Diedering provide a new method for delivering, positioning, and/or repositioning a collapsible and expandable stent frame within a patient’s heart chamber.
Share this article
Share this article
ResearchAndMarkets.com s offering.
Similar to the conventional prosthetics, neural prosthesis or neuroprosthesis are devices that restore or replace the function or a damaged part of the nervous system. Some of such neuroprostheses such as cochlear implant restore the sensory input with simulation to the nervous system. Retinal implant is another breakthrough sensory neuroprosthesis. Both these devices involve transduction of sensory information from the outer environment to the nervous system. Conversely, the nervous system can also be used as a means of signals for neural prosthesis. In paralysis treatment, information from brain motor areas are used for controlling external devices, thus restoring the movement of paralyzed limb. Another group of neuroprosthetics devices is used in neuromodulation. Deep brain stimulation improves or restores the movements in patients with Parkinson s disease and essential tremors and is also being used for